Structure of Dolutegravir
CAS No.: 1051375-16-6
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Dolutegravir (S/GSK1349572) is a highly potent and orally bioavailable HIV integrase strand transfer inhibitor with an IC50 of 2.7 nM for HIV-1 integrase-catalyzed strand transfer. Dolutegravir (S/GSK1349572) inhibits HIV-1 viral replication with an IC50 of 0.51 nM in peripheral blood mononuclear cells and maintains high potency against the HIV-1 Y143R, N155H, and G140S/Q148H mutants (EC50 = 3.6-5.8 nM).
Synonyms: S/GSK1349572; GSK1349572
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 1051375-16-6 |
Formula : | C20H19F2N3O5 |
M.W : | 419.38 |
SMILES Code : | O=C(C1=CN(C2=C(O)C1=O)C[C@]3([H])OCC[C@@H](C)N3C2=O)NCC4=CC=C(F)C=C4F |
Synonyms : |
S/GSK1349572; GSK1349572
|
MDL No. : | MFCD20488027 |
InChI Key : | RHWKPHLQXYSBKR-BMIGLBTASA-N |
Pubchem ID : | 54726191 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Description |
Dolutegravir is a highly potent and orally bioavailable inhibitor of HIV integrase strand transfer, with an IC50 of 2.7 nM for HIV-1 integrase-catalyzed strand transfer. It effectively inhibits HIV-1 viral replication with an IC50 of 0.51 nM in peripheral blood mononuclear cells. Dolutegravir also maintains significant potency against HIV-1 mutants Y143R, N155H, and G140S/Q148H (EC50=3.6-5.8 nM)[1][2].
|
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT00867152 | Healthy Volunteer | Phase 1 | Completed | - | United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less << |
NCT00858455 | Healthy Volunteer | Phase 1 | Completed | - | United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less << |
NCT01302847 | HIV Infections | Phase 1 Phase 2 | Recruiting | June 30, 2023 | - |
NCT01231542 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 1 | Completed | - | United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21287-5554 Less << |
NCT02178592 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 3 | Active, not recruiting | December 31, 2019 | - |
NCT02831673 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 3 | Active, not recruiting | March 3, 2020 | - |
NCT00708110 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 2 | Completed | - | United States, California ... More >> GSK Investigational Site Bakersfield, California, United States, 93301 GSK Investigational Site Long Beach, California, United States, 90813 GSK Investigational Site Newport Beach, California, United States, 92663 GSK Investigational Site Northridge, California, United States, 91325 GSK Investigational Site San Francisco, California, United States, 94115 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80220 United States, District of Columbia GSK Investigational Site Washington, District of Columbia, United States, 20009 United States, Florida GSK Investigational Site Fort Lauderdale, Florida, United States, 33316 GSK Investigational Site Ft. Lauderdale, Florida, United States, 33306 GSK Investigational Site Orlando, Florida, United States, 32803 GSK Investigational Site Vero Beach, Florida, United States, 32960 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30308 United States, New Jersey GSK Investigational Site Hillsborough, New Jersey, United States, 08844 GSK Investigational Site Voorhees, New Jersey, United States, 08043 United States, New Mexico GSK Investigational Site Santa Fe, New Mexico, United States, 87505 United States, North Carolina GSK Investigational Site Charlotte, North Carolina, United States, 28209 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75204 GSK Investigational Site Dallas, Texas, United States, 75246 Less << |
NCT00708110 | - | Completed | - | - | |
NCT03327740 | - | Active, not recruiting | June 30, 2019 | - | |
NCT00828763 | Healthy Volunteer | Phase 1 | Completed | - | United States, Wisconsin ... More >> GSK Investigational Site Madison, Wisconsin, United States, 53704 Less << |
NCT00996021 | Healthy Subjects | Phase 1 | Completed | - | United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less << |
NCT00883935 | Healthy Volunteer | Phase 1 | Completed | - | United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less << |
NCT00774735 | Healthy Subjects ... More >> Infection, Human Immunodeficiency Virus Less << | Phase 1 | Completed | - | United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less << |
NCT03095638 | HIV Infections | Phase 1 | Completed | - | United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less << |
NCT00555035 | Healthy Subjects | PHASE1 | COMPLETED | 2025-02-08 | GSK Investigational Site, Evan... More >>sville, Indiana, 47714, United States Less << |
NCT02486133 | HIV-Infection | Phase 3 | Active, not recruiting | December 2018 | Germany ... More >> Klinikum rechts der Isar Munich, Germany, 81675 Less << |
NCT02878642 | - | Recruiting | - | France ... More >> Caen University Hospital Recruiting Caen, France, 14000 Contact: Jean Jacques PARIENTI, MD, PhD parienti-jj@chu-caen.fr Less << | |
NCT01622790 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 1 | Completed | - | United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less << |
NCT01332565 | Infection, Human Immunodeficie... More >>ncy Virus Less << | PHASE1 | COMPLETED | 2025-06-11 | GSK Investigational Site, Cypr... More >>ess, California, 90630, United States Less << |
NCT00726336 | Healthy Subjects | Phase 1 | Completed | - | United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less << |
NCT02987530 | HIV-1 Infection | Phase 3 | Active, not recruiting | December 2019 | France ... More >> All The Regions Of The Country (40 Centers), France Less << |
NCT03360682 | HIV-1-infection ... More >> Solid Organ Transplant Less << | Phase 4 | Recruiting | January 2020 | Spain ... More >> Hospital Clínico y provincial de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Anna Cruceta Arboles, MD +34 93 2275400 ext 4380 acruceta@clinic.ub.es Less << |
NCT01449929 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 3 | Completed | - | - |
NCT01231529 | Healthy Subjects|Hepatic Impai... More >>rment|Infection, Human Immunodeficiency Virus|HIV Infections Less << | PHASE1 | COMPLETED | 2011-06-04 | GSK Investigational Site, Minn... More >>eapolis, Minnesota, 55404, United States Less << |
NCT01449929 | - | Completed | - | - | |
NCT01536873 | Infection, Human Immunodeficie... More >>ncy Virus|HIV Infections Less << | COMPLETED | 2016-09-23 | GSK Investigational Site, Phoe... More >>nix, Arizona, 85012, United States|GSK Investigational Site, San Francisco, California, 94115, United States|GSK Investigational Site, Denver, Colorado, 80218, United States|GSK Investigational Site, Fort Lauderdale, Florida, 33311, United States|GSK Investigational Site, Fort Lauderdale, Florida, 33316, United States|GSK Investigational Site, Orlando, Florida, 32803, United States|GSK Investigational Site, Saint Petersburg, Florida, 33701, United States|GSK Investigational Site, Vero Beach, Florida, 32960, United States|GSK Investigational Site, Atlanta, Georgia, 30322, United States|GSK Investigational Site, Chicago, Illinois, 60612, United States|GSK Investigational Site, Chicago, Illinois, 60613, United States|GSK Investigational Site, Chicago, Illinois, 60657, United States|GSK Investigational Site, Topeka, Kansas, 66606, United States|GSK Investigational Site, Saint Louis, Missouri, 63139, United States|GSK Investigational Site, Omaha, Nebraska, 68198, United States|GSK Investigational Site, Bronx, New York, 1057, United States|GSK Investigational Site, New York, New York, 10011, United States|GSK Investigational Site, Chapel Hill, North Carolina, 27599-7215, United States|GSK Investigational Site, Lancaster, Pennsylvania, 17604, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19107, United States|GSK Investigational Site, Austin, Texas, 78705, United States|GSK Investigational Site, Dallas, Texas, 75204, United States|GSK Investigational Site, Houston, Texas, 77004, United States|GSK Investigational Site, Houston, Texas, 77098, United States|GSK Investigational Site, Graz, A-8020, Austria|GSK Investigational Site, Linz, A-4020, Austria|GSK Investigational Site, Vienna, A-1140, Austria|GSK Investigational Site, Antwerpen, 2000, Belgium|GSK Investigational Site, Brussels, 1000, Belgium|GSK Investigational Site, Liege, 4000, Belgium|GSK Investigational Site, Ipanema, Rio De Janeiro, 22410-906, Brazil|GSK Investigational Site, Macae, Rio De Janeiro, 27910-210, Brazil|GSK Investigational Site, Porto Alegre, Rio Grande Do Sul, 2006, Brazil|GSK Investigational Site, Sao Paulo, S?o Paulo, 04121-000, Brazil|GSK Investigational Site, Fortaleza, 60455-610, Brazil|GSK Investigational Site, Maceió, 57035-110, Brazil|GSK Investigational Site, Ribeir?o Preto, 14048-900, Brazil|GSK Investigational Site, Rio de Janeiro, 20520-054, Brazil|GSK Investigational Site, Rio de Janeiro, 20725-090, Brazil|GSK Investigational Site, Rio de Janeiro, 21040-900, Brazil|GSK Investigational Site, Sao Paulo, 01246-000, Brazil|GSK Investigational Site, Vittoria, 29020-020, Brazil|GSK Investigational Site, Vancouver, British Columbia, V6Z 1Y6, Canada|GSK Investigational Site, Hamilton, Ontario, L8N3Z5, Canada|GSK Investigational Site, Toronto, Ontario, M5G 1K2, Canada|GSK Investigational Site, Montreal, Quebec, H2L 4P9, Canada|GSK Investigational Site, Bordeaux cedex, 33076, France|GSK Investigational Site, Le Kremlin-Bicêtre Cedex, 94275, France|GSK Investigational Site, Marseille, 13274, France|GSK Investigational Site, Nice, 06202, France|GSK Investigational Site, Paris Cedex 10, 75475, France|GSK Investigational Site, Paris Cedex 14, 75679, France|GSK Investigational Site, Paris Cedex 18, 75877, France|GSK Investigational Site, Paris Cedex 20, 75970, France|GSK Investigational Site, Paris, 75012, France|GSK Investigational Site, Paris, 75013, France|GSK Investigational Site, Paris, 75015, France|GSK Investigational Site, Freiburg, Baden-Wuerttemberg, 79106, Germany|GSK Investigational Site, Stuttgart, Baden-Wuerttemberg, 70197, Germany|GSK Investigational Site, Frankfurt, Hessen, 60596, Germany|GSK Investigational Site, Osnabrueck, Niedersachsen, 49090, Germany|GSK Investigational Site, Bonn, Nordrhein-Westfalen, 53127, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, 50674, Germany|GSK Investigational Site, Luebeck, Schleswig-Holstein, 23538, Germany|GSK Investigational Site, Mannheim, 68161, Germany|GSK Investigational Site, Genova, Liguria, 16128, Italy|GSK Investigational Site, Genova, Liguria, 16132, Italy|GSK Investigational Site, Milano, Lombardia, 20127, Italy|GSK Investigational Site, Pavia, Lombardia, 27100, Italy|GSK Investigational Site, Bagno A Ripoli (FI), Toscana, 50011, Italy|GSK Investigational Site, Firenze, Toscana, 50134, Italy|GSK Investigational Site, Modena, 41124, Italy|GSK Investigational Site, Venezia, 30122, Italy|GSK Investigational Site, Szczecin, 71-455, Poland Less << | |
NCT03760458 | HIV Infections | Phase 1 Phase 2 | Not yet recruiting | August 2023 | United States, Illinois ... More >> Lurie Children's Hospital of Chicago (LCH) CRS Not yet recruiting Chicago, Illinois, United States, 60614-3393 Contact: Margaret Ann Sanders, M.P.H. 312-227-8275 msanders@luriechildrens.org Less << |
NCT01209065 | Infections, Human Immunodefici... More >>ency Virus and Herpesviridae Less << | Phase 1 | Completed | - | United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less << |
NCT03078556 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 1 | Completed | - | United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less << |
NCT02893488 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 1 | Completed | - | United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less << |
NCT03198884 | - | Active, not recruiting | May 1, 2018 | - | |
NCT03683524 | HIV-1 Infection | Phase 4 | Not yet recruiting | October 2020 | - |
NCT01098526 | Infections, Human Immunodefici... More >>ency Virus and Herpesviridae Less << | Phase 1 | Completed | - | United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less << |
NCT01404806 | Healthy Adult Females | Phase 1 | Completed | - | United States, North Carolina ... More >> University of North Carolina, Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less << |
NCT02370979 | HIV-1 Infection | Phase 4 | Unknown | July 2017 | France ... More >> Centre hospitalier de Belfort-Montbéliard Active, not recruiting Belfort, France, 90000 Centre hospitalier de Colmar Recruiting Colmar, France, 68024 Contact: Martin MARTINOT, MD martin.martinot@ch-colmar.fr Centre hospitalier de Mulhouse Recruiting Mulhouse Cedex, France, 68070 Contact: Geneviève BECK WIRTH, MD beck-wirthg@ch-mulhouse.fr Hôpitaux Universitaire de Strasbourg Recruiting Strasbourg Cedex, France, 67091 Contact: David REY, PhD david.rey@chru-strasbourg.fr Less << |
NCT02384395 | HIV Acute HIV... More >> Infection Less << | Not Applicable | Recruiting | July 2021 | United States, North Carolina ... More >> University of North Carolina Recruiting Chapel Hill, North Carolina, United States, 27599 Duke University Health System Recruiting Durham, North Carolina, United States, 27710 Contact: Kara McGee, MSPH, PA-C 919-668-0242 kara.mcgee@duke.edu Principal Investigator: Mehri McKellar, MD Less << |
NCT02513147 | HIV-1 | Phase 4 | Completed | - | Spain ... More >> Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Less << |
NCT02738931 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 1 | Completed | - | United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less << |
NCT00774111 | Healthy Subjects | PHASE1 | COMPLETED | 2025-12-08 | GSK Investigational Site, Buff... More >>alo, New York, 14202, United States Less << |
NCT00631592 | Healthy Subjects | PHASE1 | COMPLETED | 2025-06-08 | GSK Investigational Site, Madi... More >>son, Wisconsin, 53704, United States Less << |
NCT01366547 | Healthy Subjects ... More >> Infection, Human Immunodeficiency Virus Less << | Phase 1 | Completed | - | United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less << |
NCT01762995 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 1 | Completed | - | - |
NCT02777229 | HIV-1 Infection | Phase 3 | Active, not recruiting | July 2018 | Cameroon ... More >> Cité verte Hospital Yaoundé, Cameroon Hopital Central Yaoundé, Cameroon Military Hospital Yaoundé, Cameroon Less << |
NCT00950859 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 2 | Completed | - | - |
NCT02069834 | HIV Infection ... More >> HAART-treated Virologically Controlled Less << | Phase 2 Phase 3 | Withdrawn(One of the both Fund... More >>er partners decided to stop the study before the initiation thus no product provided and no funding to realize the study) Less << | October 2017 | France ... More >> CHU Guadeloupe Point-a-pitre, Guadeloupe, France, 97159 CHU de Fort de France Fort de France, Martinique, France, 87261 Chu Jean Minjoz Besançon, France, 25030 Hôpital Avicenne Bobigny, France, 93000 Hôpital Jean Verdier Bondy, France, 93140 CHU de Bordeaux Bordeaux, France, 33076 CHU de DIJON Dijon, France, 21079 CHD La Roche sur Yon La Roche sur Yon, France, 85925 CHU Kremlin Bicêtre Le Kremlin Bicetre, France, 94275 Hôpital Perpetuel Secours Levallois-perret, France, 92300 CHU de Nantes Nantes, France, 44093 Hôpital Saint Louis Paris Cedex 10, France, 75475 CHU BICHAT - Claude Bernard Paris cedex 18, France, 75877 CHU Hôtel Dieu Paris Paris, France, 75004 Hôpital La Pitié Salpêtrière Paris, France, 75013 Hôpital Necker - enfants Malades Paris, France, 75015 Hôpital Européen Georges Pompidou Paris, France, 75908 CHU de Rennes - Hôpital Pontchaillou Rennes, France, 35000 CH Delafontaine Saint Denis, France, 93200 CHU Saint Etienne Saint Etienne, France, 42055 CHU de Strasbourg Strasbourg, France, 67091 Hôpital FOCH Suresnes, France, 92150 CHU Toulouse Toulouse, France, 31059 CHRU de Tours Tours Cedex 09, France, 37044 CHU de Nancy VANDOEUVRE LES NANCY cedex, France, 54511 Less << |
NCT02064374 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 1 | Completed | - | United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less << |
NCT02656511 | HIV | Phase 4 | Recruiting | April 2020 | United States, California ... More >> San Francisco General Hospital Recruiting San Francisco, California, United States, 94110 Contact: Sulggi A Lee, MD PhD Sulggi.Lee@ucsf.edu Contact: Steven G Deeks, MD Steven.Deeks@ucsf.edu Less << |
NCT02337322 | Acquired Immune Deficiency Syn... More >>drome Virus Less << | Phase 4 | Active, not recruiting | December 2019 | Spain ... More >> Hospital Clinic of Barcelona Barcelona, BCN, Spain, 08013 Less << |
NCT00950859 | - | Completed | - | - | |
NCT02582684 | HIV-1 Infection | Phase 2 | Completed | - | - |
NCT01098513 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 1 | Completed | - | United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less << |
NCT02715479 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 1 | Completed | - | United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less << |
NCT01827540 | HIV-infection/AIDS | Phase 1 | Completed | - | United States, Florida ... More >> SeaView Research, Inc. Miami, Florida, United States, 33126 Less << |
NCT02582684 | - | Completed | - | - | |
NCT01382238 | Infections, Human Immunodefici... More >>ency Virus and Herpesviridae Less << | Phase 1 | Completed | - | United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less << |
NCT02659761 | Human Immunodeficiency Virus | Phase 4 | Recruiting | March 2019 | Ireland ... More >> Mater Misericordiae University Hospital Recruiting Dublin, Ireland, 7 Contact: Willard Tinago, PhD wtinago@gmail.com Contact: Patrick WG Mallon, MB BCh, PhD, FRCPI paddy.mallon@ucd.ie Principal Investigator: Patrick Mallon, MB BCh, PhD, FRCPI Sub-Investigator: Gerard Sheehan, MB BCh BAO, FRCPI Sub-Investigator: John Lambert, MD, PhD Less << |
NCT03017872 | HIV Infections | Phase 4 | Recruiting | December 28, 2021 | Argentina ... More >> Hospital G de Agudos JM Ramos Mejia Not yet recruiting Buenos Aires, Ciudad De Buenos Aires, Argentina, C1221ADC Contact: Marcelo Losso 5411 4127 0276 mlosso@hivramos.org.ar Contact: Guillermo Viloria 5411 4931 5252 gviloria@hivramos.org.ar Principal Investigator: Marcelo Losso, M.D. Hospital Dr Diego Paroissien Not yet recruiting Isidro Casanova, Provincia De Buenos Aires, Argentina, 1765 Contact: Eduardo Warley 5411 1541 897 181 eduwarley@yahoo.com.ar Contact: Maria Ines Vieni 5411 1136 877 377 ext 3340 inesvieni@gmail.com Principal Investigator: Eduardo Warley, M.D. CAICI Not yet recruiting Rosario, Provincia De Santa Fe, Argentina, S2000PBJ Contact: Sergio Lupo 54 9 341 515 7704 drsergiolupo@gmail.com Contact: Luciana Peroni 54 341 424 8045 administracioncaici@gmail.com Principal Investigator: Sergio Lupo, M.D. Hospital Interzonal de Agudos San Juan de Dios Recruiting La Plata, Argentina, 1900 Contact: Martha Michaan +54 9221 5765 131 mgmichaan@yahoo.com.ar Principal Investigator: Martha Michaan, M.D. Brazil Laboratório de Pesquisa Clinica Em Hiv/Aids - Instituto Nacional de Infectologia - Fiocruz Not yet recruiting Rio de Janeiro, Brazil, 21040-360 Contact: Beatriz Grinsztejn +552122707064 beatriz.grinsztejn@gmail.com Contact: Kelly Gama +552138659614 kelly.gama@ini.fiocruz.br Principal Investigator: Beatriz Grinsztejn, MD, PhD Chile Hospital San Borja-Arriaran Not yet recruiting Santiago, Chile, 8360159 Contact: Marcelo Wolff 562- 555 6206 marcewolff@yahoo.com Contact: Gladys Allendes 562-555-6206 gladys_allendes@yahoo.es Principal Investigator: Marcelo Wolff, MD Colombia ASISTENCIA Cientifica De Alta Complejidad S.A.S. Not yet recruiting Bogota, Colombia, 110010 Contact: Otto Sussmann 57-1- 5107600 ext 104 osussmann@gmail.com Contact: Ana Julia Rojas 57-1-5107600 ext 128 coord.investigaciones@asistenciacientifica.com Principal Investigator: Otto Sussmann, M.D. Guinea Centre de traitementambulatoire de Donka ( Hopital de jour) Not yet recruiting Conakry, Guinea, BP:5845 Contact: Mohamed Cisse +224 622 292 590 cissebibi1@gmail.com Contact: Thierno Mamadou Tounkara +224 622 318 171 tounkm@yahoo.fr Principal Investigator: Mohamed Cisse, Prof. India YRG Care Not yet recruiting Chennai, Tamil Nadu, India, 600113 Contact: Nagalingeswaran Kumarasamy 91 917 691 2007 kumarasamy@yrgcare.org Contact: Faith Beulah 91 44 39106811 beulah@yrgcare.org Principal Investigator: Nagalingeswaran Kumarasamy, MD Malaysia University of Malaya Medical Centre Recruiting Kuala Lumpur, Malaysia, 59100 Contact: Raja Iskandar Shah Raja Azwa 603-79493834 iskandar.azwa@gmail.com Contact: Margaret Tan 603-79492622 margarettan455@gmail.com Principal Investigator: Raja Iskandar Shah Raja Azwa, MBChB, MRCP Mali University of Sciences, Techniques and Technologies of Mali, University Clinical Research Center (UCRC) Not yet recruiting Bamako, Mali Contact: Sounkalo Doa +223 72274971 sounkalod@icermali.org Contact: Yacouba Cissoko +22374567649 or +22397195994 ycissoko@hotmail.com Principal Investigator: Sounkalo Doa, Prof. Mexico Morales Vargas Centro de Investigacion SC Not yet recruiting León, Guanajuato, Mexico, 37000 Contact: Juan Luis Mosqueda Gomez +52 (477) 1310037 luis_mosqueda@yahoo.com Contact: Jorge Morales Vargas +52 (477) 7160714 mnc.jorge@hotmail.com Hospital Civil de Guadalajara Not yet recruiting Guadalajara, Jalisco, Mexico, 44280 Contact: Jaime Andrade-Villanueva jandradev@msn.com Contact: Angeles González-Hernández 5233 3614 7586 angelesghdez1@gmail.com Principal Investigator: Jaime Andrade-Villanueva, M.D. Instituto Nacional de Ciencias Medicas y Nutriciòn Salvador Zubiran Not yet recruiting Mexico City, Mexico, 14080 Contact: Juan Sierra Madero 52 5556559675 jsmadero@yahoo.com Contact: Izchel Loyo iz.inncm@outlook.com Principal Investigator: Juan Sierra Madero, M.D. Nigeria Institute of Human Virology, Nigeria (IHVN) Not yet recruiting Abuja, Nigeria, 9396 Contact: Ernest Ekong +2348023107612 ernestekong@ihvnigeria.org Contact: Nnakelu Eriobu +2347039469273 neriobu@ihvnigeria.org Principal Investigator: Ernest Ekong, MD South Africa Desmond Tutu HIV Foundation Recruiting Cape Town, South Africa, 7925 Contact: Richard Kaplan Richard.Kaplan@hiv-research.org.za Contact: Christie Heiberg 27 21 406 3621 Christie.Heiberg@hiv-research.org.za Principal Investigator: Richard Kaplan, M.D. Clinical HIV Research Unit (CHRU), Wits Health Consotium (Pty) Ltd Recruiting Johannesburg, South Africa, 2041 Contact: Noluthando Mwelase tmwelase@witshealth.co.za Contact: Pauline Vunandala 27 11 276 8800 pvunandlala@witshealth.co.za Principal Investigator: Noluthando Mwelase, MBCHB Perinatal HIV Research Unit (PHRU), Chris Hani Baragwanath Hospital Recruiting Soweto, South Africa, 1864 Contact: Lerato Mohapi mohapil@hivsa.com Contact: Debra Peters 27 11 989 9700 petersd@phru.co.za Principal Investigator: Lerato Mohapi, BSc, MBBCh Thailand HIV-NAT (The HIV Netherlands Australia Thailand Research Collaboration), Thai Red Cross AIDS Research Centre Recruiting Bangkok, Thailand, 10330 Contact: Anchalee Avihingsanon +662 652 3040 ext 107 anchaleea2009@gmail.com Contact: Kanitta Pussadee +662 652 3040 ext 202 kanitta.p@hivnat.org Principal Investigator: Anchalee Avihingsanon, M.D. Chiangrai Prachanukroh Hospital Not yet recruiting Chiang Rai, Thailand, 57000 Contact: Pacharee Kantipong 66818859195 pachareek@hotmail.com Contact: Supawadee Pongprapass 66819616900 npudit@hotmail.com Principal Investigator: Pacharee Kantipong, M.D. Srinagarind Hospital, Khon Kaen University Recruiting Khon Kaen, Thailand, 40002 Contact: Ploenchan Chetchotisakd 6643363168 ploencha@kku.ac.th Contact: Anchalee Tiyabut 6643363169 atiyabut@yahoo.com Principal Investigator: Ploenchan Chetchotisakd, M.D. Bamrasnaradura Infectious Diseases Institute Recruiting Nonthaburi, Thailand, 11000 Contact: Weerawat Manosuthi drweerawat@hotmail.com Contact: Supeda Thongyen 6625903631 supeda_t@yahoo.com Principal Investigator: Weerawat Manosuthi, M.D. Zimbabwe University of Zimbabwe Clinical Research Centre Recruiting Harare, Zimbabwe, +263 Contact: James G Hakim 263 772225489 Jhakim@mweb.co.zw Contact: Shepherd Mudzingwa 263 4 701717 smudzingwa@yahoo.com Principal Investigator: James G Hakim, M.D. Less << |
NCT01467518 | Infections, Human Immunodefici... More >>ency Virus and Hepatitis Less << | Phase 1 | Completed | - | Canada, Ontario ... More >> GSK Investigational Site Toronto, Ontario, Canada, M5V 2T3 Less << |
NCT02219217 | HIV | Phase 1 | Completed | - | United Kingdom ... More >> St Stephen's AIDS Trust London, United Kingdom, SW10 9NH Less << |
NCT02185300 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 1 | Completed | - | United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less << |
NCT02218320 | - | Completed | - | United States, North Carolina ... More >> Clinical and Translational Research Center, UNC Hospitals Chapel Hill, North Carolina, United States, 27599 Less << | |
NCT02218320 | - | Completed | - | - | |
NCT02211690 | Human Immunodeficiency Virus | Phase 4 | Completed | - | Australia, New South Wales ... More >> St Vincent's Hospital Centre for Applied Medical Research Darlinghurst, New South Wales, Australia, 2010 Sydney Sexual Health Centre Sydney, New South Wales, Australia, 2000 Clinic 16, Royal North Shore Hospital Sydney, New South Wales, Australia, 2065 Australia, Victoria Melbourne Sexual Health Centre Carlton, Victoria, Australia, 3053 Alfred Hospital Melbourne, Victoria, Australia, 3004 Less << |
NCT02542852 | HIV-1 Infection | Phase 2 | Recruiting | December 2017 | Italy ... More >> Ospedale San Raffaele Scientific Institute Recruiting Milan, Italy, 20127 Less << |
NCT03336346 | - | Recruiting | December 2018 | Botswana ... More >> Botswana-UPenn Partnership Recruiting Gaborone, Botswana Contact: Chelsea Morroni, MD 26776524112 chelseaamorroni@gmail.com Principal Investigator: Chelsea Morroni, MD Less << | |
NCT02067767 | HIV-1 Infection | Phase 2 | Completed | - | France ... More >> La Roche-sur-Yon Hospital La Roche-sur-Yon, France Nantes University Hospital Nantes, France Less << |
NCT02499978 | HIV/AIDS | Phase 2 Phase 3 | Withdrawn | - | United States, California ... More >> Stanford Univerity Stanford, California, United States, 94305 United States, Colorado University of Colorado Aurora, Colorado, United States, 80045 Less << |
NCT01467531 | Infections, Human Immunodefici... More >>ency Virus and Hepatitis Less << | Phase 1 | Completed | - | United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less << |
NCT02242799 | Malaria HIV | Phase 1 | Completed | - | Uganda ... More >> Infectious Diseases Institute Kampala, Uganda Less << |
NCT03033836 | HIV Infections | Phase 4 | Active, not recruiting | July 2019 | Argentina ... More >> Fundacion Huesped Ciudad de Buenos Aires, Buenos Aires, Argentina, C1202ABB Less << |
NCT01966822 | HIV-1 Infection | Phase 3 | Completed | - | Spain ... More >> GermansTrias i Pujol Hospital Badalona, Barcelona, Spain, 08916 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Clínico San Carlos Madrid, Spain, 28040 Less << |
NCT03493568 | HIV-1-infection | Phase 3 | Recruiting | July 31, 2020 | Italy ... More >> Ospedale San Raffaele Recruiting Milan, Lombardia, Italy, 20127 Contact: ADRIANO LAZZARIN 0226437939 lazzarin.adriano@hsr.it Contact: Elisabetta Carini 0226437934 carini.elisabetta@hsr.it Ospedale San Raffaele Scientific Institute Recruiting Milan, Italy, 20127 Less << |
NCT01425099 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 1 | Completed | - | United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less << |
NCT02596334 | HIV | Phase 3 | Terminated(5 patients on tivic... More >>ay had virological failure) Less << | - | France ... More >> CHD de VENDEE La Roche sur Yon, France, 85925 CH de LA ROCHELLE La Rochelle, France, 17019 CHRU de NANTES Nantes, France, 44093 CH de NIORT Niort, France, 79021 CHR d'ORLEANS Orleans, France, 45032 CHRU de POITIERS Poitiers, France, 86021 CHU de STRASBOURG Strasbourg, France, 67000 CHRU de TOURS Tours, France, 37044 CHU de NANCY Vandoeuvre Les Nancy, France, 54511 Less << |
NCT01499199 | Infection, Human Immunodeficie... More >>ncy Virus Less << | PHASE3 | COMPLETED | 2025-05-14 | GSK Investigational Site, Los ... More >>Angeles, California, 90069, United States|GSK Investigational Site, San Diego, California, 92103, United States|GSK Investigational Site, Providence, Rhode Island, 02906, United States Less << |
NCT01499199 | Infection, Human Immunodeficie... More >>ncy Virus Less << | PHASE3 | COMPLETED | 2025-05-14 | GSK Investigational Site, Los ... More >>Angeles, California, 90069, United States|GSK Investigational Site, San Diego, California, 92103, United States|GSK Investigational Site, Providence, Rhode Island, 02906, United States Less << |
NCT01068925 | Infection, Human Immunodeficie... More >>ncy Virus|HIV Infections Less << | PHASE1 | COMPLETED | 2010-04-05 | GSK Investigational Site, Aust... More >>in, Texas, 78744, United States Less << |
NCT02263326 | HIV Infection | Phase 3 | Completed | - | United States, California ... More >> University of California San Diego San Diego, California, United States United States, Georgia Emory University Atlanta, Georgia, United States United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Massachusetts Brigham and Women's Hospital Boston, Massachusetts, United States United States, New York Cornell University New York, New York, United States United States, Ohio University of Cincinnati Cincinnati, Ohio, United States The Ohio State University Columbus, Ohio, United States Less << |
NCT03249181 | HIV-1-infection ... More >> Pregnancy Related Less << | Phase 3 | Active, not recruiting | March 2021 | South Africa ... More >> University of Cape Town Cape Town, Western Cape, South Africa Uganda Infectious Diseases Institute Kampala, Uganda Less << |
NCT01459315 | Healthy | Phase 1 | Completed | - | United States, North Carolina ... More >> University of North Carolina, Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less << |
NCT02527096 | HIV-1 Infection | Phase 2 | Completed | - | France ... More >> Hôpital Avicenne Bobigny, France, 93009 Hôpital Saint-André Bordeaux, France, 33000 Hôpital Gabriel Montpied Clermont-Ferrand, France, 63003 Hôpital du Bocage Dijon, France, 21079 Hôpital Pierre Zobda-Quitman Fort de France, France, 97261 Hôpial Bicêtre Le Kremelin Bicêtre, France, 94270 Hôpital Gui de Chaudiac Montpellier, France, 34295 Hôpital de l'Hotel Dieu Nantes, France, 44093 Hôpital Saint-Louis Paris, France, 75010 Hôpital Saint-Antoine Paris, France, 75012 Hôpital Pitié-Salpêtrière Paris, France, 75013 Hôpital Necker Paris, France, 75015 Hôpital Bichat Paris, France, 75018 Centre hospitalier de Pernignan Perpignan, France, 66046 Hôpital Pontchaillou Rennes, France, 35033 Hôpital Purpan Toulouse, France, 31059 Hôpital Gustave Dron Tourcoing, France, 59208 Hôpital Bretonneau Tours, France, 37044 Less << |
NCT03602690 | HIV/AIDS | Phase 2 | Recruiting | October 3, 2020 | Cambodia ... More >> NCHADS Recruiting Phnom Penh, Cambodia Contact: Sun Ly Penh, MD Less << |
NCT02263326 | - | Completed | - | - | |
NCT01353716 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 1 | Completed | - | United States, Minnesota ... More >> GSK Investigational Site Minneapolis, Minnesota, United States, 55404 Less << |
NCT01328041 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 3 | Completed | - | - |
NCT02285374 | HIV | Phase 4 | Unknown | December 2015 | United Kingdom ... More >> Chelsea and Westminster Hospital London, United Kingdom, SW10 9TH Less << |
NCT01498861 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 1 | Completed | - | United States, Florida ... More >> GSK Investigational Site Miami, Florida, United States, 33169 Less << |
NCT01328041 | - | Completed | - | - | |
NCT03199690 | HIV-1-infection ... More >> Tuberculosis Less << | Phase 1 | Not yet recruiting | March 2018 | - |
NCT02551523 | Monotherapy D... More >>olutegravir Primary HIV Infection Treatment Efficacy Less << | Phase 2 | Active, not recruiting | February 2021 | Switzerland ... More >> University Hospital Zurich, University of Zurich Zurich, Switzerland, 8091 Less << |
NCT02245022 | HIV Pregnancy | Phase 2 Phase 3 | Active, not recruiting | December 2018 | South Africa ... More >> Desmond Tutu HIV Foundation Cape Town, Western Cape, South Africa Uganda Infectious Diseases Institute Kampala, Uganda Less << |
NCT02076386 | Infection, Human Immunodeficie... More >>ncy Virus Less << | COMPLETED | 2017-07-05 | GSK Investigational Site, Frei... More >>burg, Baden-Wuerttemberg, 79106, Germany|GSK Investigational Site, Mannheim, Baden-Wuerttemberg, 68161, Germany|GSK Investigational Site, Stuttgart, Baden-Wuerttemberg, 70197, Germany|GSK Investigational Site, Tuebingen, Baden-Wuerttemberg, 72076, Germany|GSK Investigational Site, Fuerth, Bayern, 90762, Germany|GSK Investigational Site, Muenchen, Bayern, 80331, Germany|GSK Investigational Site, Muenchen, Bayern, 80335, Germany|GSK Investigational Site, Muenchen, Bayern, 80336, Germany|GSK Investigational Site, Muenchen, Bayern, 80801, Germany|GSK Investigational Site, Muenchen, Bayern, 81675, Germany|GSK Investigational Site, Frankfurt am Main, Hessen, 60590, Germany|GSK Investigational Site, Frankfurt, Hessen, 60311, Germany|GSK Investigational Site, Hannover, Niedersachsen, 30159, Germany|GSK Investigational Site, Osnabrueck, Niedersachsen, 49090, Germany|GSK Investigational Site, Aachen, Nordrhein-Westfalen, 52062, Germany|GSK Investigational Site, Bochum, Nordrhein-Westfalen, 44787, Germany|GSK Investigational Site, Dortmund, Nordrhein-Westfalen, 44137, Germany|GSK Investigational Site, Duesseldorf, Nordrhein-Westfalen, 40237, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, 50674, Germany|GSK Investigational Site, Muenster, Nordrhein-Westfalen, 48143, Germany|GSK Investigational Site, Koblenz, Rheinland-Pfalz, 56073, Germany|GSK Investigational Site, Mainz, Rheinland-Pfalz, 55116, Germany|GSK Investigational Site, Magdeburg, Sachsen-Anhalt, 39120, Germany|GSK Investigational Site, Berlin, 10243, Germany|GSK Investigational Site, Berlin, 10405, Germany|GSK Investigational Site, Berlin, 10439, Germany|GSK Investigational Site, Berlin, 10707, Germany|GSK Investigational Site, Berlin, 10777, Germany|GSK Investigational Site, Berlin, 10961, Germany|GSK Investigational Site, Berlin, 13347, Germany|GSK Investigational Site, Berlin, 14057, Germany|GSK Investigational Site, Chemnitz, 09111, Germany|GSK Investigational Site, Hamburg, 20099, Germany|GSK Investigational Site, Hamburg, 20146, Germany|GSK Investigational Site, Hamburg, 20246, Germany|GSK Investigational Site, Koeln, 50668, Germany|GSK Investigational Site, Koeln, 50679, Germany|GSK Investigational Site, Weimar, 99427, Germany Less << | |
NCT03224338 | HIV II Infection | Phase 2 | Recruiting | June 2019 | Portugal ... More >> Centro Hospitalar de Lisboa Central Hospital Curry Cabral Recruiting Lisboa, Portugal Principal Investigator: Fernando Maltez, MD Centro Hospitalar de Lisboa Ocidental Hospital de Egas Moniz Recruiting Lisboa, Portugal Principal Investigator: Kamal Mansinho, MD Centro Hospitalar Lisboa Norte Hospital de Santa Maria Recruiting Lisboa, Portugal Principal Investigator: Nuno Janeiro, MD Hospital Beatriz Ângelo Loures Recruiting Lisboa, Portugal Principal Investigator: Paulo Rodrigues, MD Hospital Garcia de Orta Recruiting Lisboa, Portugal Principal Investigator: Nuno Marques, MD Hospital Professor Doutor Fernando Fonseca Amadora Recruiting Lisboa, Portugal Principal Investigator: Patricia Pacheco, MD Less << |
NCT03094507 | HIV | Phase 1 | Completed | - | United Kingdom ... More >> St Stephen's Centre London, United Kingdom, SW10 9NH Less << |
NCT02211482 | HIV-1 Infection | Phase 4 | Completed | - | Argentina ... More >> Fundacion Huesped Caba, Buenos Aires, Argentina, C1202ABB Less << |
NCT02404805 | HIV Hepatitis... More >> C Less << | Not Applicable | Completed | - | United States, Colorado ... More >> University of Colorado Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less << |
NCT02976259 | HIV Infection Primary | PHASE3 | COMPLETED | 2025-12-18 | - |
NCT01568892 | HIV Infections | Phase 3 | Completed | - | - |
NCT02572947 | Human Immunodeficiency Virus|D... More >>olutegravir|Monotherapy|Treatment Efficacy Less << | PHASE2 | COMPLETED | 2025-09-17 | University Hospitals of Geneva... More >>, HIV unit, Geneva, 1205, Switzerland Less << |
NCT01568892 | - | Completed | - | - | |
NCT02098837 | HIV | PHASE4 | COMPLETED | 2017-12-04 | Insititute Of Tropical Medicin... More >>e Antwerp, Antwerp, B-2000, Belgium|CHU Saint-Pierre, Brussels, 100, Belgium|Universitaire Ziekenhuis Gent, Gent, 9000, Belgium|Hopital de la Croix Rousse, Lyon, 69004, France|Service des Maladies Infectieuses et Tropicales du CHU de NANTES, Nantes, 44093, France|Hopital Saint Louis, Paris, 75010, France|Pitié-Salpêtrière Hospital, Paris, 75013, France|Hospital Bichat Claude-Bernard, Paris, 75018, France|Universit?tsklinikum Bonn, Bonn, 53127, Germany|Universit?tsklinikum Essen, Essen, 45147, Germany|Klinikum der Goethe-Universit?t Frankfurt, Frankfurt, 60590, Germany|ICH Infektiologisches Centrum Hamburg, Hamburg, 20146, Germany|Medizinische Hochschule Hannover, Hannover, 30625, Germany|Santa Maria Annunziata di Firenze, Firenze, 50011, Italy|San Paolo Hospital, Milan, 20142, Italy|Azienda Ospedaliera - Polo Universitario 'Luigi Sacco', Milan, 20157, Italy|Universitaria di Modena, Modena, 41124, Italy|Universitario Alicante, Alicante, 03010, Spain|Hospital General Universitario de Elche, Alicante, 03203, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, 08025, Spain|Hospital Clinic Barcelona, Barcelona, 08036, Spain|Universitari de Bellvitge, Barcelona, 08907, Spain|IrsiCaixa, Barcelona, 08916, Spain|Hospital Ramon y Cajal, Madrid, 28034, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Elton John Centre, Brighton, BN2 1ES, United Kingdom|Southmead Hospital, Bristol, BS10 5NB, United Kingdom|Bart's Hospital, London, E1 1BB, United Kingdom|Royal Free Hospital, London, NW3 2QG, United Kingdom|St Thomas Hospital, London, SE1 7EH, United Kingdom|Chelsea & Westminster Hospital, London, Sw10 9NH, United Kingdom|St Mary's Hospital, London, W2 1NY, United Kingdom|Mortimer Market Centre, London, WC1E 6JB, United Kingdom Less << |
NCT02509195 | HIV | Phase 4 | Completed | - | United Kingdom ... More >> St Stephen's Centre, Chelsea & Westminster Hospital London, United Kingdom, SW10 9NH Less << |
NCT02500446 | HIV | Phase 4 | Completed | - | Australia, Victoria ... More >> Melbourne Sexual Health Centre Carlton, Victoria, Australia, 3053 Alfred Hospital Prahran, Victoria, Australia, 3010 Less << |
NCT02491242 | - | Completed | - | Spain ... More >> Ramon y Cajal Hospital Madrid, Spain, 28034 Less << | |
NCT02924389 | HIV | Not Applicable | Recruiting | June 2020 | United States, Georgia ... More >> Grady Health System Recruiting Atlanta, Georgia, United States, 30303 Contact: Cecile Lahiri, MD 404-616-6306 cdelill@emory.edu Ponce De Leon Center Recruiting Atlanta, Georgia, United States, 30308 Contact: Cecile Lahiri, MD 404-616-6306 cdelill@emory.edu Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Cecile Lahiri, MD 404-616-6306 cdelill@emory.edu Less << |
NCT02401828 | Human Immunodeficiency Virus | PHASE4 | COMPLETED | 2025-07-17 | Erasmus Medical Center, Rotter... More >>dam, Zuid Holland, 3000 CA, Netherlands Less << |
NCT03016533 | HIV Infections | Phase 3 | Recruiting | December 29, 2023 | South Africa ... More >> GSK Investigational Site Recruiting Hillbrow, Gauteng, South Africa, 2001 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Thailand GSK Investigational Site Recruiting Chiang Mai, Thailand, 50200 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Less << |
NCT02487706 | HIV | PHASE4 | COMPLETED | 2025-07-15 | Germans Trias i Pujol Hospital... More >>, Badalona, Barcelona, 08916, Spain Less << |
NCT02566707 | HIV-1 Infection | Phase 2 | Terminated(due to introduction... More >> of another integrase inhibitor, recruitement was not feasible anymore.) Less << | - | Germany ... More >> University of Bonn Bonn, Germany Netherlands Rijstate Arnhem, Netherlands Radboud University Nijmegen Medical Centre Nijmegen, Netherlands St. Elisabeth Tilburg, Netherlands Less << |
NCT05590325 | Hiv | PHASE1|PHASE2 | RECRUITING | 2024-12-31 | Tygerberg Hospital, Cape Town,... More >> Western Cape, 7505, South Africa Less << |
NCT04166474 | Hiv|Tuberculosis | PHASE4 | COMPLETED | 2024-02-07 | Desmond Tutu Health Foundation... More >>, Cape Town, South Africa|Infectious Diseases Institute, Kampala, Uganda Less << |
NCT03813979 | HIV-1-infection|Hepatic Impair... More >>ment Less << | PHASE4 | WITHDRAWN | 2021-12-31 | - |
NCT04238767 | HIV-1-infection | COMPLETED | 2021-05-20 | Butha-Buthe Government Hospita... More >>l, Butha-Buthe, Lesotho|Seboche Mission Hospital, Butha-Buthe, Lesotho Less << | |
NCT04771754 | HIV-1-infection on Healthy Vol... More >>unteers Less << | PHASE1 | COMPLETED | 2024-01-10 | Arnold Xhikola, London, SW10 0... More >>XD, United Kingdom Less << |
NCT04229290 | HIV-1-infection | PHASE4 | COMPLETED | 2021-09-16 | Kiambu Level 5 Hospital, Kiamb... More >>u, Kenya|Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya|Kenyatta National Hospital, Nairobi, Kenya|Thika Level 5 Hospital, Thika, Kenya Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.38mL 0.48mL 0.24mL |
11.92mL 2.38mL 1.19mL |
23.84mL 4.77mL 2.38mL |